Advances in clinical NK cell studies: Donor selection, manufacturing and quality control Jul 20, 2023 | Uncategorized
CD19-CAR engineered NK-92 cells are sufficient to overcome NK cell resistance in B-cell malignancies Jul 20, 2023 | Uncategorized
Continuously expanding CAR NK-92 cells display selective cytotoxicity against B-cell leukemia and lymphoma Jul 20, 2023 | Uncategorized
Direct and antibody-dependent cell-mediated cytotoxicity of head and neck squamous cell carcinoma cells by high-affinity natural killer cells Jul 20, 2023 | Uncategorized
Inability of granule polarization by NK cells defines tumor resistance and can be overcome by CAR or ADCC mediated targeting Jul 19, 2023 | Uncategorized
